We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+5.72%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$824M
AUM Growth
+$36.1M
Cap. Flow
+$24.8M
Cap. Flow %
3.01%
Top 10 Hldgs %
72.89%
Holding
30
New
2
Increased
8
Reduced
10
Closed
3

Top Buys

Rank Stock Value
1
AGEN
Agenus
AGEN
+$17.5M
2
HNSN
HANSEN MEDICAL, INC. COM NEW
HNSN
+$17.2M
3
PGEN icon
Precigen
PGEN
+$6.73M
4
CFRX
ContraFect Corporation
CFRX
+$5.99M
5
MZOR
Mazor Robotics Ltd.
MZOR
+$3.09M

Top Sells

Rank Stock Value
1
ACOR
Acorda Therapeutics
ACOR
+$7.37M
2
RGLS
Regulus Therapeutics
RGLS
+$7.33M
3
ABEO icon
Abeona Therapeutics
ABEO
+$4.24M
4
TSRO
TESARO, Inc.
TSRO
+$3.64M
5
NXTM
NxStage Medical Inc.
NXTM
+$3.07M

Sector Composition

Rank Sector Weight
1 Healthcare 75.91%
2 Consumer Staples 0.52%
3 Financials 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXDX
1
DELISTED
Accelerate Diagnostics
AXDX
$140M 16.99%
542,589
– –
OPK icon
2
Opko Health
OPK
$978M
$79.7M 9.68%
4,959,335
– –
QDEL icon
3
QuidelOrtho
QDEL
$1.21B
$66.5M 8.06%
2,895,808
-19,825
-0.7% -$462K
THOR
4
DELISTED
THORATEC CORPORATION
THOR
$54.8M 6.65%
1,229,600
-3,000
-0.2% -$131K
NXTM
5
DELISTED
NxStage Medical Inc.
NXTM
$51M 6.19%
3,572,963
-181,380
-5% -$3.07M
CMRX
6
DELISTED
Chimerix, Inc.
CMRX
$47.4M 5.75%
1,025,921
+62,023
+6% +$2.49M
PGEN icon
7
Precigen
PGEN
$2.36B
$42.8M 5.19%
884,391
+159,707
+22% +$6.73M
HNSN
8
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$41.1M 4.99%
4,491,819
+1,889,021
+73% +$17.2M
MZOR
9
DELISTED
Mazor Robotics Ltd.
MZOR
$32.5M 3.94%
2,439,237
+240,967
+11% +$3.09M
AGEN
10
Agenus
AGEN
$326M
$30.9M 3.75%
182,380
+123,014
+207% +$17.5M
TSRO
11
DELISTED
TESARO, Inc.
TSRO
$29M 3.52%
493,000
-63,379
-11% -$3.64M
ACOR
12
DELISTED
Acorda Therapeutics
ACOR
$27.2M 3.3%
6,799
-1,908
-22% -$7.37M
ARAY icon
13
Accuray
ARAY
$32.2M
$21.4M 2.6%
3,176,838
-189,378
-6% -$1.41M
PACB icon
14
Pacific Biosciences
PACB
$441M
$18.7M 2.27%
3,241,761
-43,035
-1% -$249K
BIOL
15
DELISTED
Biolase, Inc.
BIOL
$18.2M 2.21%
838
– –
VRML
16
DELISTED
Vermillion, Inc.
VRML
$16.8M 2.04%
8,112,182
– –
AMRN
17
Amarin Corp
AMRN
$297M
$12.8M 1.55%
259,211
+2,639
+1% +$119K
WBMD
18
DELISTED
WebMD Health Corp.
WBMD
$10.5M 1.28%
238,103
– –
TTHI
19
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
$10.2M 1.24%
4,863,914
+2,593
+0.1% +$18.2K
RGLS
20
DELISTED
Regulus Therapeutics
RGLS
$8.13M 0.99%
6,182
-4,544
-42% -$7.33M
CFRX
21
DELISTED
ContraFect Corporation
CFRX
$6.21M 0.75%
+1,478
New +$5.99M
YTEN
22
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$4.33M 0.52%
120
-6
-5% -$247K
BIIB icon
23
Biogen
BIIB
$29.8B
$3.12M 0.38%
7,723
– –
TCRT icon
24
Alaunos Therapeutics
TCRT
$4.65M
$2.91M 0.35%
+1,614
New +$2.51M
VANI icon
25
Vivani Medical
VANI
$115M
$2.86M 0.35%
8,750
– –
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q2 2015 Portfolio in Review

As of Q2 2015, Oracle Investment Management held 30 positions worth $824M, up 4.6% from $788M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Oracle Investment Management deployed $24.8M of net new capital in Q2 2015, opening 2 new positions and adding to 8 existing holdings. Its largest new stake was ContraFect Corporation: 1,478 shares worth $6.21M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 78% a quarter earlier, followed by Consumer Staples and Financials.

On the sell side, the largest reduction was Acorda Therapeutics, an estimated $7.37M trimmed.

  • Oracle Investment Management's largest Q2 2015 buy was ContraFect Corporation: 1,478 shares worth $6.21M.
  • Oracle Investment Management added most to Agenus in Q2 2015, an estimated $17.5M increase.
  • Oracle Investment Management's biggest Q2 2015 reduction was Acorda Therapeutics, cutting an estimated $7.37M.
  • Oracle Investment Management fully exited Abeona Therapeutics in Q2 2015, selling an estimated $4.24M.
  • Oracle Investment Management's ten largest holdings make up 73% of its $824M portfolio in Q2 2015.
  • Oracle Investment Management opened 2 new positions and closed 3 in Q2 2015.
  • Oracle Investment Management's portfolio value rose 4.6% quarter-over-quarter to $824M.

Based on Oracle Investment Management's 13F filing for Q2 2015, filed 14 Aug 2015.